Evidence map›Paper›PMID 34097754›Full record

ArticleClinical pharmacology and therapeutics2021

Pharmacogenomics and Vaccine Development.

Gregory A Poland, Inna G Ovsyannikova, Richard B Kennedy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pharmacology and therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gregory A PolandMayo Clinic Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Inna G OvsyannikovaMayo Clinic Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Richard B KennedyMayo Clinic Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

The Immunogenetics of Measles ImmunityR01AI033144 · NIAID · MAYO CLINIC ROCHESTER · PI POLAND, GREGORY A. · 1993 to 2022
$8.1M
Systems Biology of Mumps Vaccine ResponseR01AI138965 · NIAID · MAYO CLINIC ROCHESTER · PI KENNEDY, RICHARD B · 2018 to 2022
$3.9M
Transcriptomic Signatures of Influenza Vaccine ResponsesR01AI132348 · NIAID · MAYO CLINIC ROCHESTER · PI KENNEDY, RICHARD B, POLAND, GREGORY A. · 2018 to 2022
$3.9M
Understanding measles vaccine failure (and success) in Southern IndiaR01AI121054 · NIAID · MAYO CLINIC ROCHESTER · PI JACOB, JOSHY, KENNEDY, RICHARD B · 2017 to 2021
$3.8M
Genetic Markers of Long-Term Mumps Vaccine ImmunityR01AI127365 · NIAID · MAYO CLINIC ROCHESTER · PI KENNEDY, RICHARD B · 2016 to 2020
$3.6M
NIAID NIH HHS R01 AI033144NIAID NIH HHS R01 AI121054NIAID NIH HHS R01 AI127365NIAID NIH HHS R01 AI132348NIAID NIH HHS R01 AI138965
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug DevelopmentPharmacogeneticsAnimalsHumansProteomicsSystems BiologyVaccinesVaccines

Identifiers

PMID34097754
PMCPMC8239825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.